Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Felix

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Human Mutation|December 23, 2011
Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/-) stem cellsAngelika C Roehl, Tanja Mussotter, David N Cooper, et al.
Molecular Genetics & Genomic Medicine|May 21, 2018
Co-occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1Hildegard Kehrer-Sawatzki, Uwe Kordes, Simone Seiffert, et al.
The Journal of Investigative Dermatology|January 11, 2013
Functional MHC class II is upregulated in neurofibromin-deficient Schwann cellsDavid E Reuss, Jana Mucha, Nikola Holtkamp, et al.
Human Mutation|May 28, 2010
A novel third type of recurrent NF1 microdeletion mediated by nonallelic homologous recombination between LRRC37B-containing low-copy repeats in 17q11.2Kathrin Bengesser, David N Cooper, Katharina Steinmann, et al.
Nucleic Acids Research|October 24, 2009
GeMInA, Genomic Metadata for Infectious Agents, a geospatial surveillance pathogen databaseLynn M Schriml, Cesar Arze, Suvarna Nadendla, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|March 8, 2012
Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomasChristian Hagel, Anat O Stemmer-Rachamimov, Antje Bornemann, et al.
Pediatric Blood & Cancer|June 8, 2021
Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6Uwe Kordes, Victor-Felix Mautner, Florian Oyen, et al.
Diagnostics (Basel, Switzerland)|December 3, 2020
Assessment of Peripheral Nervous System Alterations in Patients with the Fabry Related <i>GLA</i>-Variant p.A143TTim Godel, Katharina V Cossel, Reinhard E Friedrich, et al.
Cancers|April 3, 2021
Risk Stratification for Immediate Postoperative Hearing Loss by Preoperative BAER (Brainstem Auditory Evoked Response) and Audiometry in NF2-Associated Vestibular SchwannomasIsabel Gugel, Florian Grimm, Philip Hartjen, et al.
Journal of Medical Genetics|June 10, 2010
Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1Douglas R Stewart, Jennifer L Sloan, Lawrence Yao, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Human Mutation|December 23, 2011
Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/-) stem cellsAngelika C Roehl, Tanja Mussotter, David N Cooper, et al.
Molecular Genetics & Genomic Medicine|May 21, 2018
Co-occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1Hildegard Kehrer-Sawatzki, Uwe Kordes, Simone Seiffert, et al.
The Journal of Investigative Dermatology|January 11, 2013
Functional MHC class II is upregulated in neurofibromin-deficient Schwann cellsDavid E Reuss, Jana Mucha, Nikola Holtkamp, et al.
Human Mutation|May 28, 2010
A novel third type of recurrent NF1 microdeletion mediated by nonallelic homologous recombination between LRRC37B-containing low-copy repeats in 17q11.2Kathrin Bengesser, David N Cooper, Katharina Steinmann, et al.
Nucleic Acids Research|October 24, 2009
GeMInA, Genomic Metadata for Infectious Agents, a geospatial surveillance pathogen databaseLynn M Schriml, Cesar Arze, Suvarna Nadendla, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|March 8, 2012
Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomasChristian Hagel, Anat O Stemmer-Rachamimov, Antje Bornemann, et al.
Pediatric Blood & Cancer|June 8, 2021
Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6Uwe Kordes, Victor-Felix Mautner, Florian Oyen, et al.
Diagnostics (Basel, Switzerland)|December 3, 2020
Assessment of Peripheral Nervous System Alterations in Patients with the Fabry Related <i>GLA</i>-Variant p.A143TTim Godel, Katharina V Cossel, Reinhard E Friedrich, et al.
Cancers|April 3, 2021
Risk Stratification for Immediate Postoperative Hearing Loss by Preoperative BAER (Brainstem Auditory Evoked Response) and Audiometry in NF2-Associated Vestibular SchwannomasIsabel Gugel, Florian Grimm, Philip Hartjen, et al.
Journal of Medical Genetics|June 10, 2010
Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1Douglas R Stewart, Jennifer L Sloan, Lawrence Yao, et al.
Pageof 15